| Code | Description | Total Paid |
|---|
| J9271 |
Injection, pembrolizumab, 1 mg |
$11.84M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
$10.48M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
$9.11M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
$7.69M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
$7.11M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
$5.23M |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
$5.01M |
| 41899 |
Unlisted procedure, dentoalveolar structures |
$4.94M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
$4.87M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
$4.18M |